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The papers in this research topic are focused on the extraordinary tale of cyclic GMP: its recogni-
tion as a hormonal second messenger and its subsequent interplay with intracellular calcium where
the two together become co-messengers in cellular signal transduction processes. In this emerging
thememembrane guanylate cyclases sense intracellular as well as extracellular signals. Four original
research and 12 review articles sample the extraordinary progress that has been made in the field.
The topic introduces the present status of the field with a figure illustrating that cyclic GMP
is generated by two structurally different guanylate cyclases, soluble and the membrane form
(Figure 1: Sharma and Duda, 2014). The synthetic machinery and the modes of their operation
by which they generate cyclic GMP are entirely different, and so are their physiologically regulated
processes. Since many of the membrane guanylate cyclases carry multiple names and all names
remain in use, the review also provides a guide to the current nomenclature of the membrane
guanylate cyclases (Introductory text Table 1). Then it moves on with a lively historical perspec-
tive, replete with unexpected twists and turns. Current research suggests that new developments
will continue to follow a tortuous but always exciting path! Guanylate cyclase activating proteins or
GCAPs are neuronal calcium sensing proteins that serve as subunits in the ROS-GC complex. The
review article by Lim et al. (2014) delves into the molecular mechanism by which GCAPs inhibit
GC activity when [Ca2+]i is high and stimulate it when [Ca2+]i is low. As it turns out, GCAP1 has a
more subtle use for its myristoyl tail, compared to other, related neuronal calcium sensors. Besides
the additional forms of GCAPs that are being discovered (cf. Wen et al., 2014), ROS-GC1 is subject
to modulation by other Ca2+ binding proteins: S100B in retinal cones (reviewed by Sharma et al.,
2014) and S100B and neurocalcin δ (NCδ) in spermatozoa (Jankowska et al., 2014). Unlike GCAPs,
S100B and NCδ stimulate ROS-GC1 at high [Ca2+]i. Co-expression of S100B and GCAPs with
ROS-GC1 in the same cells empowers ROS-GC1 with the ability to operate as a novel, bimodal
Ca2+ switch wherein guanylate cyclase activity is elevated at very high and at very low [Ca2+]i.
Transduction of Ca2+ signals is not restricted to ROS-GCs; NCδ serves as a subunit for the trans-
duction of the ANF signal by ANF-RGC (Duda et al., 2014). Thus, NCδ, in addition to being a
“neuronal” calcium sensor, takes on responsibilities outside of neurons. If other guanylate cyclases
possess the proper sequences for NCδ, S100B and/or GCAPs interactions, their calcium sensing
paradigms will unfold in the future.
Interestingly, GCAP2 has an alternate binding partner that is not a guanylate cyclase. At the pho-
toreceptor synapse, it interacts with RIBEYE to control ribbon size (reviewed by Schmitz, 2014).
Recent work on a new ROS-GC binding partner, RD3, (reviewed by Molday et al., 2014) reveals
that it is necessary for the intracellular transport of ROS-GC. It also inhibits ROS-GC possibly as
a means of suppressing unwanted activity until the cyclase arrives at the proper cellular location.
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In retinal rods and cones, cyclic GMP produced by ROS-GCs
opens cyclic nucleotide gated cation channels in readiness for
visual transduction. Wen et al. (2014) describe the rationale for
expressing multiple forms of guanylate cyclases and GCAPs in
order to adjust photon response amplitude and quicken pho-
toresponse kinetics according to the requirements of the individ-
ual photoreceptor. Besides photoreceptors, there are cyclic GMP
pathways in place elsewhere in the retina. Dhingra et al. (2014)
have begun to probe the function of these pathways in PDE9A
knockout mice by ERG recording.
Downstream signaling pathways for natriuretic peptide recep-
tor GCs are more complex and have not yet been so well charac-
terized (reviewed by Pandey, 2014). In different systems, cyclic
GMP synthesis by natriuretic peptide receptor guanylate cyclases
decreases cyclic AMP, Ca2+, and inositol triphosphate, and
downregulates PKC (protein kinase C) and mitogen-activated
protein kinases. Barmashenko et al. (2014) present intriguing
experiments in rats with reduced expression of C-type natri-
uretic peptide receptor guanylate cyclase, CNP-RGC. In neu-
ronal recordings from hippocampus, long term potentiation
was enhanced while long term depression was reduced. The
changes in neuronal excitability were accompanied by increased
exploratory behavior and improved object recognition.
Failure to synthesize cyclic GMP properly can cause severe
forms of blindness in early childhood. Disruptions in RD3 cause
Leber congenital amaurosis (Molday et al., 2014). In a research
article, Zägel and Koch (2014) explain how three separate point
mutations that cause another form of Leber congenital amau-
rosis, progressive cone degeneration, and juvenile retinitis pig-
mentosa, respectively, alter ROS-GC1 biochemistry. Boye (2014)
summarizes promising results of experiments in which gene
replacement therapy was used to correct faulty ROS-GC1 func-
tion in animal models with recessive retinal disease. Prospects
for clinical trials are discussed. Dominant forms of retinal degen-
eration call for a different approach. The application of RNA
interference to attenuate faulty ROS-GC activity caused by muta-
tions in GCAP1 suggests that it may be a viable option (reviewed
by Jiang et al., 2014). Glaucoma is yet another major cause of
blindness, in this case, due to compromise of retinal ganglion
cell function. Buys et al. (2014) examine studies on a major risk
factor, elevated intraocular pressure, and the link to cyclic GMP
synthesis by both soluble and membrane guanylate cyclases. We
conclude the topic with a review by Hannig et al. (2014), that
outlines the involvement of STa-RGC in the sensation of visceral
pain and how a synthetic peptide may provide relief to patients
suffering from abdominal pain.
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